Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Person › Details

Frank Kalkbrenner (Boehringer Ingelheim Venture Fund (BIVF))

Kalkbrenner, Frank (Boehringer 201308 CVP + Head of BIVF + CEO Acousia Therapeutics GmbH)


Organisations Organisation Boehringer Ingelheim Venture Fund (BIVF)
  Former/major organisation Acousia Therapeutics GmbH
Products Product venture capital
  Product 2 drug development

Record changed: 2020-08-06


Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Frank Kalkbrenner

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] Back into Ad 650x80px

» top